Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Observational × Exenatide × Clear all

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Blood Specimen Collection 103 Surveys and Questionnaires 67 Observation 39 Radiotherapy 38 Drug Therapy 33 Surgical Procedures, Operative 28 Biopsy 27 Specimen Handling 25 Data Collection 25 Interviews as Topic 19 Magnetic Resonance Imaging 18 Watchful Waiting 16 Liquid Biopsy 16 Magnetic Resonance Spectroscopy 15 Immune Checkpoint Inhibitors 15 pembrolizumab 11 Radiosurgery 11 Tomography, X-Ray Computed 10 Standard of Care 10 Nivolumab 10 Immunotherapy 10 lenvatinib 9 Ultrasonography 9 Radiation 9 Neoadjuvant Therapy 9 Tissue Banks 8 Diagnostic Imaging 8 Cisplatin 8 Chemoradiotherapy 8 Carboplatin 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05663515 2026-02-12

EXCEED

AstraZeneca

24,000 enrolled

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡